Company: OFIX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-061062
Chunk: 33

Company: Orthofix Medical Inc.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 33
---
 of Conduct training.                             |
| Supplier Quality Manual: This manual communicates our expectations to all new and existing suppliers to ensure the delivery of high-quality products to our customers. Topics include ethics, compliance with laws and regulations, human rights, labor and employment, health and safety, environmental responsibility, business conduct, and fair dealing.                                                                                  |
| Sustainability: This policy guides our approach to environmental and social risk management within our Corporate Code of Conduct. Areas of focus include our corporate compliance with responsible hazardous waste protocols, recycling, emergency preparedness, and programs to enhance and promote environmental stewardship.                                                                                                               |

<div align='center'>25</div>

| Engagement with Shareholders                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| We proactively engage with shareholders throughout the year to better understand their priorities and perspectives, carefully considering the feedback we receive and acting when appropriate. We do this through annual meetings, investor relations events, and by providing information on our website, including proxy statements and press releases, to foster transparency and communication. We also review the results of the annual advisory vote on executive compensation in making determinations about the structure of our executive compensation program and whether changes to the program should be considered. |

For more information on our Corporate Responsibility program, or to read our ESG Fact Sheet, please visit our corporate website: https://ir.orthofix.com/governance/corporate-sustainability/default.aspx

<div align='center'>26</div>

| CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS |

Compensation Committee Interlocks and Insider Participation The Compensation and Talent Development Committee, comprised entirely of independent, non-management directors, is responsible for establishing and administering the Company’s policies involving the compensation of its executive officers. No member of the Compensation and Talent Development Committee (i) was, during the year ended December 31, 2024, or has previously been, an officer or employee of the Company, or (ii) had any material interest in a transaction with the Company or a business relationship with, or any indebtedness, to the Company. No interlocking relationships existed during the year ended December 31, 2024 between any member of the Board or the Compensation and Talent Development Committee and an executive officer of the Company. Approval of Related Person Transactions Our policy regarding transactions with related persons, which is set forth in our Corporate Code of Conduct and Audit and Finance Committee charter, is that the Audit and Finance Committee will review and approve or ratify all transactions between the Company and any related person (as defined in Item 404 of Regulation S